BioLineRx (BLRX) Misses Q1 EPS by 1c

May 14, 2019 7:08 AM

BioLineRx (NASDAQ: BLRX) reported Q1 EPS of ($0.06), $0.01 worse than the analyst estimate of ($0.05)."As we progress through 2019 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found